Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive
MONDO:0011086A rare, genetic T-B- severe combined immunodeficiency disorder due to null mutations in recombination activating gene (RAG) 1 and/or RAG2 resulting in less than 1% of wild type V(D)J recombination activity. Patients present with neonatal onset of life-threatening, severe, recurrent infections by opportunistic fungal, viral and bacterial micro-organisms, as well as skin rashes, chronic diarrhea, failure to thrive and fever. Immunologic observations include profound T- and B-cell lymphopenia, normal NK counts and low or absent serum immunoglobulins; some patients may have eosinophilia.
Also known as: SCID due to complete RAG1/2 deficiency, severe combined immunodeficiency, B cell-negative, severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive, SCID, AR, T-cell negative, B-cell negative, NK cell-positive, SCID, T cell-negative, B cell-negative, NK cell-positive, severe combined immunodeficiency due to complete RAG1/2 deficiency, severe immunodeficiency, autosomal recessive, T-cell negative, B-cell negative, NK cell-positive
4 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Gene therapy offers hope for 'Bubble Boy' disease without a donor
Disease control TerminatedThis trial tests a gene therapy for infants under 2 years old with RAG1-deficient severe combined immunodeficiency (SCID), a life-threatening condition where the immune system barely works. The therapy uses the child's own blood stem cells, modified with a corrected gene, to try …
Phase: PHASE1, PHASE2 • Sponsor: Videja B.V. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC